{
  "title": "A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria TrialCurrent perspectives of urine-based tests for screening and post-treatment monitoring of urothelial carcinoma of the bladderEditorial Comment.Editorial Comment.Microhematuria: AUA/SUFU guidelineComparison of the harms, advantages, and costs associated with alternative guidelines for the evaluation of hematuriaDisparities in the diagnostic evaluation of microhematuria and implications for the detection of urologic malignancyQuality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic reviewEvaluation of the new American Urological Association guidelines risk classification for hematuriaA segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinomaUrinary analysis of FGFR3 and TERT gene mutations enhances performance of Cxbladder tests and improves patient risk stratificationA multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuriaReduction of pain during flexible cystoscopy: a systematic review and meta-analysisDiscomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopyLife cycle assessment of reusable and disposable cystoscopes: a path to greener urological proceduresPerformance characteristics of a multigene urine biomarker test for monitoring for recurrent urothelial carcinoma in a multicenter studyAssessment of a clinical pathway for investigation of haematuria that reduces the need for cystoscopyCxbladder monitor testing to reduce cystoscopy frequency in patients with bladder cancerBudgetary impact of including the urinary genomic marker Cxbladder detect in the evaluation of microhematuria patients",
  "pmcid": "12721662",
  "features": {
    "sample_size": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "sample size"
      ],
      "examples": [
        {
          "match": "sample size",
          "context": "age; QC, quality control. The sample size of approximately 180 LR subje"
        }
      ]
    },
    "randomization": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "randomized controlled trial"
      ],
      "examples": [
        {
          "match": "Randomized Controlled Trial",
          "context": "A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to"
        }
      ]
    },
    "blinding": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "allocation_concealment": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "interaction_subgroup": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "stratification"
      ],
      "examples": [
        {
          "match": "stratification",
          "context": "sts and improves patient risk stratificationA multigene urine test for the"
        },
        {
          "match": "stratification",
          "context": "ne test for the detection and stratification of bladder cancer in patients"
        },
        {
          "match": "stratification",
          "context": "differ from current guideline stratification. Those who didn\u2019t fulfill all"
        }
      ]
    },
    "variable_definitions": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "primary endpoint"
      ],
      "examples": [
        {
          "match": "primary endpoint",
          "context": "analysis for calculating the primary endpoint (clinical utility) vs the sec"
        }
      ]
    },
    "analysis_principles": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "itt_details": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "software": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "r, version 4.2.10"
      ],
      "examples": [
        {
          "match": "R, version 4.2.10",
          "context": "are 95%. Analysis was done in R, version 4.2.10 CAPTION: Demographics FOOTER:"
        }
      ]
    },
    "error_measures": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "sd",
        "standard deviation",
        "standard error"
      ],
      "examples": [
        {
          "match": "standard deviation",
          "context": "est; NLR, not lower risk; SD, standard deviation. CAPTION: Incidence of Cystos"
        },
        {
          "match": "standard error",
          "context": "based on the formula for the standard error of the log relative risk rati"
        },
        {
          "match": "SD",
          "context": "sk test; NLR, not lower risk; SD, standard deviation. CAPTION:"
        }
      ]
    },
    "multiplicity_correction": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "normality_checks": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "p_values": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "secondary endpoint"
      ],
      "examples": [
        {
          "match": "secondary endpoint",
          "context": "int (clinical utility) vs the secondary endpoint (clinical validity). To be in"
        }
      ]
    },
    "confidence_intervals": {
      "present": true,
      "count": 7,
      "unique_matches": [
        "confidence interval"
      ],
      "examples": [
        {
          "match": "confidence interval",
          "context": "les. We derived estimates and confidence intervals for the absolute and relativ"
        },
        {
          "match": "Confidence interval",
          "context": "rates, comparing the groups. Confidence intervals for the absolute change are"
        },
        {
          "match": "Confidence interval",
          "context": "proportions (prop.test in R). Confidence intervals for the difference in the re"
        }
      ]
    },
    "comparative_stats": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "relative risk"
      ],
      "examples": [
        {
          "match": "relative risk",
          "context": "als for the difference in the relative risk are based on the formula for"
        },
        {
          "match": "relative risk",
          "context": "the standard error of the log relative risk ratio.9 The difference betwee"
        },
        {
          "match": "relative risk",
          "context": "value 0 (absolute rate) or 1 (relative risk). For those subjects where bo"
        }
      ]
    },
    "non_parametric": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "advanced_modeling": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "assumption_checks": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "survival_analysis": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "regression_and_models": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "reporting_guidelines": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "consort"
      ],
      "examples": [
        {
          "match": "CONSORT",
          "context": "ing to the analysis reported. CONSORT diagrams. A, diagram for all"
        }
      ]
    },
    "data_types": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "proportions"
      ],
      "examples": [
        {
          "match": "proportions",
          "context": "re based on the test of equal proportions (prop.test in R). Confidence"
        }
      ]
    },
    "dependency": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "clustering": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "missing_data": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "effect_size": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "relative risk"
      ],
      "examples": [
        {
          "match": "relative risk",
          "context": "als for the difference in the relative risk are based on the formula for"
        },
        {
          "match": "relative risk",
          "context": "the standard error of the log relative risk ratio.9 The difference betwee"
        },
        {
          "match": "relative risk",
          "context": "value 0 (absolute rate) or 1 (relative risk). For those subjects where bo"
        }
      ]
    },
    "post_hoc": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "baseline_reporting": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "advanced_modeling_extra": {
      "present": true,
      "count": 2,
      "unique_matches": [
        "categorization",
        "categorized"
      ],
      "examples": [
        {
          "match": "categorized",
          "context": "vided urine for a CxbT. Those categorized as lower risk (LR), defined a"
        },
        {
          "match": "categorization",
          "context": "the AUA 2020 guidelines, the categorization was based on number of RBCs p"
        }
      ]
    },
    "systematic_review_metrics": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "diagnostic_metrics": {
      "present": true,
      "count": 11,
      "unique_matches": [
        "positive predictive value",
        "npv",
        "specificity",
        "sensitivity"
      ],
      "examples": [
        {
          "match": "sensitivity",
          "context": "cs of the test by calculating sensitivity, specificity, NPV, and test n"
        },
        {
          "match": "sensitivity",
          "context": "low probability of UC with a sensitivity of 95.1% and NPV of 98.5%. Th"
        },
        {
          "match": "sensitivity",
          "context": "were known, we calculated the sensitivity, specificity, NPV, positive p"
        }
      ]
    },
    "model_details": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "domain_indicators": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "microscopy"
      ],
      "examples": [
        {
          "match": "microscopy",
          "context": "nt gross hematuria, and urine microscopy showing 3 to 29 red blood cel"
        }
      ]
    }
  },
  "feedback": {
    "overall_score": 8.5,
    "rigor_rating": "High",
    "critical_gaps": [
      {
        "message": "Categorical data mentioned, but no appropriate categorical tests found.",
        "evidence": "...re based on the test of equal proportions (prop.test in R). Confidence..."
      }
    ],
    "strengths": [
      {
        "message": "Analysis context identifies basic science or bioinformatics (Softened clinical trial requirements).",
        "evidence": "Detected term: 'microscopy'"
      },
      {
        "message": "Detailed software versions provided.",
        "evidence": "...are 95%. Analysis was done in R, version 4.2.10 CAPTION: Demographics FOOTER:..."
      },
      {
        "message": "Reported effect sizes (e.g., OR, HR, MD) alongside statistical significance.",
        "evidence": "...als for the difference in the relative risk are based on the formula for..."
      },
      {
        "message": "Reported diagnostic metrics (AUC/ROC).",
        "evidence": "...cs of the test by calculating sensitivity, specificity, NPV, and test n..."
      }
    ],
    "actionable_recommendations": [],
    "deterministic_audit": true
  }
}